EGF and cancer: DOR and MOR are overexpressed in lung cancer [26, 27], and the overexpression of MOR enhances cancer progression by regulating Epidermal Growth Factor (EGF)-induced signalling events [28] and epithelial mesenchymal transition (EMT) events [17].